Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)

Role of non-contrast CT component of PSMA PET/CT scan in the detection of peripheral zone prostate cancer

Chandan J Das
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1507;
Chandan J Das
1Department of Radiodiagnosis and Interventional Radiology, AIIMS, New Delhi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P1507

Introduction: Prostate cancer (PCa) is the second most common malignancy to occur in men worldwide, according to the International Agency for Research on Cancer (IARC). There were an estimated 1.4 million new cases and 375,000 deaths due to PCa in 2020. The risk of PCa increases with increasing age. PCa is typically a slowly progressing disease and survival rates are excellent in early-diagnosed cases.

Few studies have recently investigated the viability of CT scans in detecting PCa. Jia et. al. and Huang et al. investigated the use of contrast-enhanced CT (CECT) in detecting peripheral zone PCa and found that a focal area of abnormally increased enhancement in the periphery of the prostate may represent a clinically significant cancer and deserves further investigation with prostate-specific antigen measurement and correlation with other clinical risk-factors for PCa. It is being reported that if a focal lesion in the peripheral zone showed attenuation over 25 HU on either non-contrast or contrast-enhanced CT, it raised strong suspicion for PCa

In the past few years, Ga-68 PSMA PET/CT has emerged as a strong complementary imaging modality to mpMRI for primary prostate cancer detection with comparable, if not better, diagnostic accuracy.

Although PSMA PET/CT scan is commonly performed for prostate cancer these days, the CT component is largely under-utilized in the evaluation of prostate cancer. The purpose of this study was to identify the sensitivity of the non-contrast CT component of PSMA PET/CT based on its attenuation as measured by HU level in the detection of prostate cancer, taking PSMA PET as gold standard.

Methods: A retrospective analysis included 50 biopsy-proven prostate cancer patients between April 2018 and March 2022 who underwent staging whole body PSMA/CT prior to treatment. The control subjects were 50 randomly selected adult male patients who underwent PET/CT for non-prostate malignancy during the same time period.

Two readers independently calculated the Hounsfield unit (HU) of the normal peripheral zone, central zone, and corresponding PSMA avid focus in cases.

Results: There was no significant difference between the normal peripheral zone HU of the two groups. A significant difference in the mean HU was seen between the PSMA avid focus and the normal peripheral zone of cases and controls. ROC curve analysis revealed a mean HU cut-off of >34.9 for detecting PCa with a sensitivity and specificity of 86% and 90% respectively between cases and controls (AUC 0.88)

Conclusions: Our study adds to the evidence that detection of clinically significant PCa is possible on routinely performed non-contrast CT scans. Radiologists should routinely look for and convey these findings to facilitate further work-up and early detection of PCa.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of non-contrast CT component of PSMA PET/CT scan in the detection of peripheral zone prostate cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Role of non-contrast CT component of PSMA PET/CT scan in the detection of peripheral zone prostate cancer
Chandan J Das
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1507;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Role of non-contrast CT component of PSMA PET/CT scan in the detection of peripheral zone prostate cancer
Chandan J Das
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1507;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 68Ga-pentixather PET/CT for newly diagnosed multiple myeloma: Comparison to 68Ga-pentixafor PET/CT
  • Predicting Tumor Response to Neoadjuvant Chemotherapy based on Pretreatment 18F-FDG PET/CT and Clinical Parameters in Locally Advanced Oral Squamous Cell Carcinoma
  • Trial in Progress: Phase 1B Study of Personalized Ultrahypofractionated Stereotactic Ablative Radiotherapy of High-Risk Prostate Cancer Guided by PET PSMA (Gallium 68 gozetotide PSMA-11) response [PULSAR ProPhet]
Show more Oncology, Basic and Translational - Technical Advances & Quantification (this would include image-guided diagnostics/therapy)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire